Author
Listed:
- Matthew H. Larson
(GRAIL, Inc.)
- Wenying Pan
(GRAIL, Inc.)
- Hyunsung John Kim
(GRAIL, Inc.)
- Ruth E. Mauntz
(GRAIL, Inc.)
- Sarah M. Stuart
(GRAIL, Inc.)
- Monica Pimentel
(GRAIL, Inc.)
- Yiqi Zhou
(GRAIL, Inc.)
- Per Knudsgaard
(GRAIL, Inc.)
- Vasiliki Demas
(GRAIL, Inc.)
- Alexander M. Aravanis
(GRAIL, Inc.)
- Arash Jamshidi
(GRAIL, Inc.)
Abstract
Cell-free RNA (cfRNA) is a promising analyte for cancer detection. However, a comprehensive assessment of cfRNA in individuals with and without cancer has not been conducted. We perform the first transcriptome-wide characterization of cfRNA in cancer (stage III breast [n = 46], lung [n = 30]) and non-cancer (n = 89) participants from the Circulating Cell-free Genome Atlas (NCT02889978). Of 57,820 annotated genes, 39,564 (68%) are not detected in cfRNA from non-cancer individuals. Within these low-noise regions, we identify tissue- and cancer-specific genes, defined as “dark channel biomarker” (DCB) genes, that are recurrently detected in individuals with cancer. DCB levels in plasma correlate with tumor shedding rate and RNA expression in matched tissue, suggesting that DCBs with high expression in tumor tissue could enhance cancer detection in patients with low levels of circulating tumor DNA. Overall, cfRNA provides a unique opportunity to detect cancer, predict the tumor tissue of origin, and determine the cancer subtype.
Suggested Citation
Matthew H. Larson & Wenying Pan & Hyunsung John Kim & Ruth E. Mauntz & Sarah M. Stuart & Monica Pimentel & Yiqi Zhou & Per Knudsgaard & Vasiliki Demas & Alexander M. Aravanis & Arash Jamshidi, 2021.
"A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection,"
Nature Communications, Nature, vol. 12(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22444-1
DOI: 10.1038/s41467-021-22444-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22444-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.